三个皮匠报告—— 严选型全行业研究报告分享下载平台,您的专属行业智库!
欢迎来到三个皮匠报告!
登录
帮助中心
首页
最新
研搜
BETA
合集
英文
会议
数据
财报库
政策库
自研报告
入驻
您的当前位置:
首页
>
行业数据
>
图表35Alnylam的双靶点siRNA结构
图表35Alnylam的双靶点siRNA结构
行业数据
下载Excel
下载图片
原图定位
图片属性
图片格式:PNG
图片大小:390KB
图片尺寸:1109*871
同报告图片
/
4
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
所属报告:
圣诺医药-小核酸赛道先驱者差异化布局肿瘤和纤维化领域-220612(40页).pdf
打包全文图表
相关数据
国内部分在研单胺神经递质靶点抗抑郁药(截至2026年7月7日)
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
收藏
行业数据
2026-07-14
原图定位
查看详情
国内部分IL-17靶点药物研发进展(截至2026年6月12日)
收藏
行业数据
2026-06-15
原图定位
查看详情
2025年中国临床试验热门靶点竞争格局
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
收藏
竞争格局
2026-04-27
原图定位
查看详情
口服SERD靶点竞争格局
收藏
竞争格局
2026-04-20
原图定位
查看详情
靶向PCSK9的siRNA药物研发竞争格局
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
收藏
竞争格局
2026-04-13
原图定位
查看详情
全球用于HTG的临床开发中靶向APOC3的siRNA候选药物
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
收藏
行业数据
2026-04-13
原图定位
查看详情
全球用于治疗血栓性疾病的临床开发中的靶向FXI的siRNA候选药物
收藏
行业数据
2026-04-13
原图定位
查看详情
全球已上市的靶向PCSK9治疗HC的siRNA药物
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
收藏
行业数据
2026-04-13
原图定位
查看详情
表7SIRNA、小分子和抗体药物模式的比较
fCDlr7nmr5Tnu7TluqYgICAgICAgICB8IHNpUk5BICAgICAgICAgICAgICAgfCDlsI/liIblrZAgICAgICAgICAgICAgfCDmipfkvZMgICAgICAgICAgICAgICAgfAp8LS0tLS0tLS0tLS0tLS0tLS0tfC0tLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLXwtLS0tLS0tLS0tLS0tLS0tLS0tLS18Cnwg5YiG5a2Q6YePICAgICAgICAgICB8IH4xNCBrRGEgICAgICAgICAgICAgfCA8NTAwIERhICAgICAgICAgICAgfCA+MTAwIGtEYSAgICAgICAgICAgIHwKfCDkvZznlKjmnLrliLYgICAgICAgICB8IOWfuuWboOihqOi+vueahOiwg+aOpyAgICAgIHwg6JuL55m96LSo55qE6LCD5o6nICAgICAgIHwg6JuL55m96LSo55qE6LCD5o6nICAgICAgICB8Cnwg54m55byC5oCnICAgICAgICAgICB8IOmrmCAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICB8IOmrmCAgICAgICAgICAgICAgICAgIHwKfCDkvZznlKjmjIHnu63ml7bpl7QgICAgIHwg6ZW/ICAgICAgICAgICAgICAgICAgfCDnn60gICAgICAgICAgICAgICAgIHwg5LitICAgICAgICAgICAgICAgICAgfAp8IOe7meiNr+mikeeOhyAgICAgICAgIHwg5q+P5pyIL+avj+Wto+W6pi/mr4/ljYrlubQgIHwg5q+P5pelICAgICAgICAgICAgICAgfCDmr4/mnIgv5q+P5Lik5Liq5pyIICAgICAgIHwKfCDnlJ/kuqfmlrnms5Uv5oiQ5pysICAgIHwg5ZCI5oiQ5oqA5pyvIC8g6YCC5bqmICAgICB8IOWMluWtpuWQiOaIkCAvIOS9jiAgICAgIHwg55Sf54mp5bel6Im6IC8g6auYICAgICAgIHwKfCDkuLTluorlvIDlj5HmiJDlip/njocgICB8IOmrmCAgICAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICB8IOS4rSAgICAgICAgICAgICAgICAgIHwKfCDlhY3nlqvljp/mgKflkoxBREHkuqfnlJ98IOS9jiAgICAgICAgICAgICAgICAgIHwg5p6B5L2OICAgICAgICAgICAgICAgfCDpq5ggICAgICAgICAgICAgICAgICB8Cnwg6I2v54mp55u45LqS5L2c55SoICAgICB8IOaegeS9jiAgICAgICAgICAgICAgICB8IOW4uOingSAgICAgICAgICAgICAgIHwg5L2OICAgICAgICAgICAgICAgICAgfAoK6LWE5paZ5p2l5rqQ77ya5LiB6aaZ5Zut44CK5bCP5qC46YW46I2v54mp5qaC6KeI5oql5ZGK44CL44CB5rmY6LSi6K+B5Yi456CU56m25omA
收藏
商业模式
2026-03-30
原图定位
查看详情
IL-11靶点竞争格局
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
收藏
竞争格局
2026-02-26
原图定位
查看详情
BDCA2靶点竞争情况
收藏
行业数据
2026-02-24
原图定位
查看详情
图7小核酸药物全球靶点分布,Top3靶点为DMD、PCSK9、AGT
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
收藏
行业数据
2026-02-03
原图定位
查看详情
靶向ALK7的siRNA药物研发格局
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
收藏
竞争格局
2026-01-14
原图定位
查看详情
全球部分Claudin18.2靶点布局
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
收藏
行业数据
2026-01-07
原图定位
查看详情
全球siRNA药物格局的主要参与者
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
收藏
竞争格局
2026-01-07
原图定位
查看详情
最新数据
全球全年龄段奶粉市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球酸奶及发酵乳制品市场规模(亿美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球药用级益生菌市场规模(百万美元)
收藏
行业数据
2026-07-30
原图定位
查看详情
全球益生菌膳食补充剂市场规模及增速
收藏
行业数据
2026-07-30
原图定位
查看详情
全球拥有AKK专利菌株的核心企业
收藏
行业数据
2026-07-30
原图定位
查看详情
公司开发的双靶点 GalNac技术的 CMC工艺相对更为简单。公司致力于开发双靶点沉默递送系统的主要原因是其协同作用在癌症治疗、抗病毒、代谢等方面具有很大潜力,相比单靶点药物或联用具有潜在更好的安全性和有效性。除公司外,目前全球只有 Alnylam在研发多靶点 siRNA药物,并且也处于探索阶段。从 CMC工艺来看,公司所使用的 GalAhead平台相比Alnylam更为简单,合成步骤和使用原料相对较少,具备潜在优势。
行业数据
原图定位
当前图表所属:
圣诺医药-小核酸赛道先驱者差异化布局肿瘤和纤维化领域-220612(40页).pdf
图表9错误翻译的蛋白质将导致疾病
图表8中心法则内容图解
图表7公司产品管线广泛而深入
图表63公司风险调整后收入预测
下载图片或Excel,需升级至尊VIP会员或「预见者」VIP
立即去升级
客服
商务合作
小程序
服务号
回到顶部
折叠
微信扫码登录
微信扫码登录
双重福利,扫码领取!
关注公众号『三个皮匠报告』,免费领取报告
1.100+最新优质行业报告
2.每周免费精选报告分享
手机快捷登录
账号登录
记住密码
忘记密码?
验证即登录,未注册将自动创建账号
获取验证码
收不到验证码注意事项
登录代表您已阅读并同意
《三个皮匠服务条款》